Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Blood ◽  
2004 ◽  
Vol 104 (2) ◽  
pp. 321-327 ◽  
Author(s):  
N. Casadevall
Sign in / Sign up

Export Citation Format

Share Document